Robeco Institutional Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Robeco Institutional Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-40,547	Closed	-$167K	–	964
2024 Q1	$167K	Hold	40,547	–	–	﹤0.01%	914
2023 Q4	$171K	Sell	40,547 -9,003	-18%	-$36.3K	﹤0.01%	917
2023 Q3	$214K	Hold	49,550	–	–	﹤0.01%	918
2023 Q2	$327K	Hold	49,550	–	–	﹤0.01%	897
2023 Q1	$336K	Hold	49,550	–	–	﹤0.01%	884
2022 Q4	$366K	Buy	49,550 +19,256	+64%	+$188K	﹤0.01%	873
2022 Q3	$300K	Buy	30,294 +24,245	+401%	+$256K	﹤0.01%	803
2022 Q2	$66K	Hold	6,049	–	–	﹤0.01%	888
2022 Q1	$68K	Hold	6,049	–	–	﹤0.01%	893
2021 Q4	$95K	Sell	6,049 -19,856	-77%	-$346K	﹤0.01%	868
2021 Q3	$444K	Buy	+25,905	New	+$454K	﹤0.01%	782

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Robeco Institutional Asset Management's VNDA Position: Q2 2024 in Review

Robeco Institutional Asset Management sold out of Vanda Pharmaceuticals (VNDA) in Q2 2024, closing a stake of 40,547 shares — an estimated $167K sold.

Robeco Institutional Asset Management first reported a position in VNDA in Q3 2021 and held it in 11 quarters. The position peaked at $444K in Q3 2021. 148 funds tracked by Wall St. Rank hold VNDA as of Q2 2024.

Robeco Institutional Asset Management reported no remaining Vanda Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Robeco Institutional Asset Management sold 40,547 Vanda Pharmaceuticals shares in Q2 2024, an estimated $167K.
Robeco Institutional Asset Management first reported a position in Vanda Pharmaceuticals in Q3 2021 and held it in 11 quarters.
Robeco Institutional Asset Management's Vanda Pharmaceuticals position peaked at $444K in Q3 2021.
148 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2024.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2024, filed 23 Jul 2024.